Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples